The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
FR901228, a novel antitumor bicyclic depsipeptide produced by chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity.
Open accessAbstract
A novel antitumor bicyclic depsipeptide, FR901228, was isolated from a broth culture of Chromobacterium violaceum No. 968 as colorless prisms and the molecular formula was determined as C24H36N4O6S2. This antibiotic reverted the transformed morphology of a Ha-ras transformant to normal, and exhibited prominent antitumor activities against murine and human tumor cell lines both in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Manual for the identification of medical bacteria.
Cowan, S. T., & Steel, K. (1965) · Cambridge University Press eBooks · Cited by 4,823
MANUAL FOR THE IDENTIFICATION OF MEDICAL BACTERIA
Neter, E. (1965) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.55.12.2047-a · Cited by 2,583
Determination of DNA base composition by reversed-phase high-performance liquid chromatography
Tamaoka, J. (1984) · FEMS Microbiology Letters · doi:10.1016/0378-1097(84)90059-4 · Cited by 2,431
Dithiothreitol, a New Protective Reagent for SH Groups*
Cleland, W. W. (1964) · Biochemistry · doi:10.1021/bi00892a002 · Cited by 1,992
Preparation of transforming deoxyribonucleic acid by phenol treatment
Saito, H., & Miura, K.-I. (1963) · Biochimica et Biophysica Acta (BBA) - Specialized Section on Nucleic Acids and Related Subjects · doi:10.1016/0926-6550(63)90386-4 · Cited by 1,808
KINO, T., HATANAKA, H., HASHIMOTO, M., NISHIYAMA, M., GOTO, T., OKUHARA, M., KOHSAKA, M., AOKI, H., & IMANAKA, H. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1249 · Cited by 1,241
Self-citationHuman EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
The ras gene family and human carcinogenesis
Bos, J. L. (1988) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(88)90004-8 · Cited by 782
Determination of the Absolute Configuration of Optically Active Compounds by Means of X-Rays
BIJVOET, J. M., PEERDEMAN, A. F., & van BOMMEL, A. J. (1951) · Nature · doi:10.1038/168271a0 · Cited by 723
UEDA, H., MANDA, T., MATSUMOTO, S., MUKUMOTO, S., NISHIGAKI, F., KAWAMURA, I., & SHIMOMURA, K. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.315 · Cited by 257
Self-citationITAZAKI, H., NAGASHIMA, K., SUGITA, K., YOSHIDA, H., KAWAMURA, Y., YASUDA, Y., MATSUMOTO, K., ISHII, K., UOTANI, N., NAKAI, H., et al. (1990) · The Journal of Antibiotics · doi:10.7164/antibiotics.43.1524 · Cited by 197
Taxonomic Significance of Cellular Fatty Acid Composition in Some Coryneform Bacteria
Suzuki, K., & Komagata, K. (1983) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-33-2-188 · Cited by 167
Feramisco, J. R., Clark, R., Wong, G., Arnheim, N., Milley, R. J., & McCormick, F. P. (1985) · Nature · doi:10.1038/314639a0 · Cited by 152
Ueda, H., Nakajima, H., Hori, Y., Goto, T., & OKUHARA, M. (1994) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.58.1579 · Cited by 144
Self-citationShigematsu, N., Ueda, H., Takase, S., Tanaka, H., Yamamoto, K., & TADA, T. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.311 · Cited by 134
Self-citationRecombinant human tumor necrosis factor‐α: Thrombus formation is a cause of anti‐tumor activity
Shimomura, K., Manda, T., Mukumoto, S., Kobayashi, K., Nakano, K., & Mori, J. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410215 · Cited by 106
Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
Manda, T., Shimomura, K., Mukumoto, S., et al. (1987) · PubMed · Cited by 68
Winter, E., & Perucho, M. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.7.2562 · Cited by 37
Manoharan, T. H., Burgess, J. A., Ho, D., Newell, C. L., & Fahl, W. E. (1985) · Carcinogenesis · doi:10.1093/carcin/6.9.1295 · Cited by 20
Cited by
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
HIF-1α pathway: role, regulation and intervention for cancer therapy
Masoud, G. N., & Li, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.007 · Cited by 1,871
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Analysis of US FDA-Approved Drugs Containing Sulfur Atoms
Scott, K. A., & Njardarson, J. T. (2018) · Topics in Current Chemistry · doi:10.1007/s41061-018-0184-5 · Cited by 1,036
Metadata
- Authors
- UEDA, H., NAKAJIMA, H., HORI, Y., FUJITA, T., NISHIMURA, M., GOTO, T., & OKUHARA, M.
- Venue
- The Journal of Antibiotics
- Published
- 1994
- Volume
- 47
- Issue
- 3
- Pages
- 301-310
- ISSN
- 0021-8820 (ISSN-L)
- 1881-1469
- OpenAlex
- W2511531422
- Cited by
- 489
- References
- 21
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.